SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 4/09/20 Innovate Biopharmaceuticals, Inc. 8-K:8 4/08/20 1:32K |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 17K
Document |
Delaware | 27-3948465 | |||
(State
or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
¨ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Common Stock $0.0001 Par Value | INNT | The Nasdaq Stock Market LLC |
Item 8.01. | Other Events. |
Innovate Biopharmaceuticals, Inc. | |||
Date:
April 9, 2020 | By: | /s/ Edward J. Sitar | |
Chief
Financial Officer |
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 4/9/20 | None on these Dates | ||
For Period end: | 4/8/20 | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/15/23 9 Meters Biopharma, Inc. 424B5 1:1.2M 3/31/21 9 Meters Biopharma, Inc. 424B5 1:1.9M 3/30/21 9 Meters Biopharma, Inc. 424B5 1:1.9M 12/11/20 9 Meters Biopharma, Inc. 424B5 1:1M 12/10/20 9 Meters Biopharma, Inc. 424B5 1:1M 10/09/20 9 Meters Biopharma, Inc. 424B5 1:1M 10/08/20 9 Meters Biopharma, Inc. S-3/A 3:1.3M 10/02/20 9 Meters Biopharma, Inc. S-3 4:1.7M 8/13/20 9 Meters Biopharma, Inc. S-8 8/13/20 3:110K 8/13/20 9 Meters Biopharma, Inc. S-8 8/13/20 3:91K |